Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Riedel

Showing results (161-170 of 219) with videos related to

Pageof 22
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2015
Effects of enhanced caregiver training program on cancer caregiver's self-efficacy, preparedness, and psychological well-beingCristina C Hendrix, Donald E Bailey, Karen E Steinhauser, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2016
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumourAndrew J Wagner, Mark Agulnik, Michael C Heinrich, et al.
The Journal of Pathology|January 28, 2006
Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasisJ-H Martens, J Kzhyshkowska, M Falkowski-Hansen, et al.
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.
Cancer Chemotherapy and Pharmacology|February 27, 2017
Phase I study of pazopanib plus TH-302 in advanced solid tumorsRichard F Riedel, Kellen L Meadows, Paula H Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2009
Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancerDavid S Hsu, Chaitanya R Acharya, Bala S Balakumaran, et al.
AJR. American Journal of Roentgenology|October 20, 2021
Dual-Energy CT Vital Iodine Tumor Burden for Response Assessment in Patients With Metastatic GIST Undergoing TKI Therapy: Comparison With Standard CT and FDG PET/CT CriteriaMathias Meyer, Peter Hohenberger, Daniel Overhoff, et al.
BMC Cancer|October 16, 2024
Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcomaMark M Cullen, Alexander L Lazarides, Patricia D Pittman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancerDavid S Hsu, Bala S Balakumaran, Chaitanya R Acharya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.
Pageof 22

Showing results (161-170 of 219) with videos related to

Sort By:
Pageof 22
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2015
Effects of enhanced caregiver training program on cancer caregiver's self-efficacy, preparedness, and psychological well-beingCristina C Hendrix, Donald E Bailey, Karen E Steinhauser, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2016
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumourAndrew J Wagner, Mark Agulnik, Michael C Heinrich, et al.
The Journal of Pathology|January 28, 2006
Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasisJ-H Martens, J Kzhyshkowska, M Falkowski-Hansen, et al.
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.
Cancer Chemotherapy and Pharmacology|February 27, 2017
Phase I study of pazopanib plus TH-302 in advanced solid tumorsRichard F Riedel, Kellen L Meadows, Paula H Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2009
Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancerDavid S Hsu, Chaitanya R Acharya, Bala S Balakumaran, et al.
AJR. American Journal of Roentgenology|October 20, 2021
Dual-Energy CT Vital Iodine Tumor Burden for Response Assessment in Patients With Metastatic GIST Undergoing TKI Therapy: Comparison With Standard CT and FDG PET/CT CriteriaMathias Meyer, Peter Hohenberger, Daniel Overhoff, et al.
BMC Cancer|October 16, 2024
Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcomaMark M Cullen, Alexander L Lazarides, Patricia D Pittman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancerDavid S Hsu, Bala S Balakumaran, Chaitanya R Acharya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.
Pageof 22